ADMA Biologics, Inc.
ADMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $36,429 | $34,218 | $26,904 | $111,896 |
| Dep. & Amort. | $2,023 | $2,058 | $2,159 | $2,163 |
| Deferred Tax | $4,803 | $1,620 | $0 | $0 |
| Stock-Based Comp. | $5,047 | $4,963 | $4,624 | $5,433 |
| Change in WC | -$37,320 | -$23,004 | -$56,893 | $9,781 |
| Other Non-Cash | $2,311 | $1,284 | $3,531 | -$79,057 |
| Operating Cash Flow | $13,293 | $21,139 | -$19,675 | $50,216 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14,368 | -$2,422 | -$4,701 | -$2,757 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$105 | -$19 | $7 |
| Investing Cash Flow | -$14,368 | -$2,527 | -$4,720 | -$2,750 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,274 | -$450 | $0 | -$30,000 |
| Stock Issued | $389 | $2,064 | $0 | $0 |
| Stock Repurch. | -$23,038 | $0 | -$7,228 | -$644 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,902 | -$1,566 | $101 | -$382 |
| Financing Cash Flow | -$27,825 | $48 | -$7,127 | -$31,026 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$28,900 | $18,660 | -$31,522 | $16,440 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $90,285 | $71,625 | $103,147 | $86,707 |
| End Cash | $61,385 | $90,285 | $71,625 | $103,147 |
| Free Cash Flow | -$1,075 | $18,717 | -$24,376 | $47,459 |